Trial Profile
Pneumococcal conjugate vaccine (Prevnar; Wyeth) with pneumococcal polysaccharide vaccine (23-valent) and tetanus/diphtheria vaccine.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Mar 2012
Price :
$35
*
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Diphtheria-tetanus vaccine; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 13 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2005 New trial record.